Skip to main content
. 2012 Aug 14;96(3):433–443. doi: 10.1093/cvr/cvs271

Figure 6.

Figure 6

Effect of CaM or GSH-CaM on Ca2+ transient and cell shortening in normal and failing cardiomyocytes. (A) Representative tracings of Ca2+ transient and cell shortening in normal and failing cardiomyocytes. (B) The characteristics of cell shortening and Ca2+ transient in normal and failing cardiomyocytes treated with RyR2 domain peptides (DPc10, 30 µmol/L, or DP4090–4123, 30 µmol/L).